Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Avalo Therapeutics, Inc. | 36,855 | reported | 21 May 2026 | tx 4+279,200−637 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Avalo Therapeutics, Inc. | 34,200 | 0.00 USD | |
| 26 Feb 2026 | GRANT_AWARD | Avalo Therapeutics, Inc. | 95,000 | 0.00 USD | deriv |
| 10 Dec 2025 | TAX_WITHHOLDING | Avalo Therapeutics, Inc. | 637 | 4.10 USD | |
| 01 Jan 2025 | GRANT_AWARD | Avalo Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |